CMP8 是一种雌激素受体的选择性配体，可结合到雌激素受体配体结合域。它能够作用于突变型 MGERα (IC50:29 nM)、MGRERα (IC50:41 nM)和野生型 HERα (IC50:1100 nM)、HERβ (IC50:2200 nM)。

CMP8 is a selective ligand for estrogen receptor. CMP8 binds to the mutant estrogen receptor ligand binding domain (ERLBD). CMP8 has IC50 values of 29 nM , 41 nM, 1100 nM and 2200 nM for MGERα, MGRERα, hERα and hERβ, respectively.

CMP8 is dosed in male Balb-c mice (4 mg/kg, ip). In mammalian cells, the plasma concentration after 4 h is 1.5-fold its EC50. It has a Cmax of 0.5 μM after 30 min.[1][2]

851107-28-3

C33H34ClNO3

528.08

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years